selina.wu@alltests.com.cn 86-571-56267891
Home
Products
Custom Monoclonal Antibody Hybridoma Monoclonal Antibody Mouse Monoclonal Antibodies Drug Abuse Test Kit Rapid Test Kit Infectious Disease Testing Accuate Cardiac Marker Rapid Test kits Convenient Oncology Rapid Diagnostic Test kits Rapid Diagnostic Test Kits Fluorescence Immunoassay Analyzer Glucose Monitoring Device Veterinary Rapid Test Kits Flourescence Immunoassay Test Kits Urine Chemistry Analyzer Nucleic Acid PCR Rapid Test Reader Chemiluminescence Immunoassay Test
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home News

Do CTCs have a predictive role in ovarian cancer?

All Categories
Tag Cloud
Contact Us
Selina

Phone Number : +86 13989889852

WhatsApp : +8613989889852

Do CTCs have a predictive role in ovarian cancer?

May 24, 2021

“Liquid biopsy” in which body fluids are screened for biomarkers like circulating tumor cells (CTCs), circulating free DNA, or exosomes are gathering substantial research and support. CTCs are shed into bloodstream from primary tumor, metastases or recurrences, and display tumor specific characteristics, rendering them good candidates for liquid biopsy.

 

Expression of EpCAM in CTC positive patients predicts chemotherapy resistance and prognosis, could aid clinicians in individualizing therapy, saving the patient from unnecessary side effects and systemic toxicity of platinum-based chemotherapy.

 

SEE MORE ABOUT TUMOR MARKER RAPID TEST: http://www.alltests.com.cn/